Atlas Trials

Bioavailability Study Comparing Tolvaptan Administered Via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact

Clinical trial NCT01261481 · COMPLETED

Trial details

NCT number
NCT01261481
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2011-01-01
Primary completion
2012-01-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.